← Open Payments lookup

MEAGAN MEFFERT: Open Payments

NPI 1649990722 · CATOOSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$962 in 45 payments from 12 companies in 2025. Trend: 2023 $335 · 2024 $1,362 · 2025 $962

Food & beverage: $954Education: $8
CompanyPaymentsAmount
GENZYME CORPORATION9$226
AstraZeneca Pharmaceuticals LP8$168
Grifols USA, LLC4$97
ABBVIE INC.4$87
GlaxoSmithKline, LLC.4$68
ARS Pharmaceuticals Operations, Inc.3$68
Takeda Pharmaceuticals U.S.A., Inc.3$59
Regeneron Healthcare Solutions, Inc.2$43
Novartis Pharmaceuticals Corporation2$41
Blueprint Medicines Corporation2$41

Products named: DUPIXENT, FASENRA, Xembify, NUCALA, NEFFY, CUVITRU, AIRSUPRA, AYVAKIT.

Industry payments across OK — which companies pay providers there.